In the final days of June 2022, as markets retreated and investor confidence frayed, a disciplined earnings-focused screen surfaced three companies — Merck, Simply Good Foods, and PNM Resources — whose profit trajectories were moving against the broader tide. Each, in its own way, embodies a quiet truth about markets: that even in periods of collective doubt, certain enterprises are quietly compounding their strength. The CAN SLIM framework, which prizes accelerating earnings above almost all else, offered these names not as certainties, but as reasoned bets on human ingenuity and institutiona
Investor's Business Daily
· Jun 30, 2022
· economy
· 4 min read
High
Sourcing: Characterized
Three stocks show analyst-backed profit growth potential amid market downturn
◉
Economy & Finance
7131 related articles
Markets await Warsh's Jackson Hole stance as Bessent intervention stir…
Google News · 100% match
Stock futures flat as Wall Street opens week lower amid oil surge and …
Google News · 99% match
30-Year Treasury Yields Hit 19-Year High Amid Bond Selloff
Google News · 99% match
Gold extends rally as rate-hike fears ease, Fed minutes eyed
CNBC · 99% match
Yen strengthens as Fed rate hike bets fade amid currency intervention …
Google News · 99% match
Related Coverage
TanzaniaInvest · Sep 04
Tanzania's Fisheries Sector Rebounds to 6.3% Growth in 2025 Amid Export Headwinds
Tanzania's fisheries sector grew 6.3% in 2025, reaching 519,454 tonnes valued at TZS 4.56 trillion and contributing a re…
SoftPower News · Sep 04 JRS Uganda Opens Market Platform for Refugee EntrepreneursJesuit Refugee Service Uganda is hosting its inaugural Open Days exhibition on September 25-26 in Kampala to connect ref…
Borkena · Sep 04 Ethiopian unions push IMF on wage floor and tax relief amid inflation surgeEthiopia's labor confederation reaffirms advocacy for a national minimum wage floor and income tax relief to combat infl…
Fibre2Fashion · Sep 04 UK Manufacturing Growth Slows in August, But Optimism Hits Six-Month HighUK manufacturing PMI fell to 51.7 in August from 51.9 in July, signaling cooling growth in output and new orders, though…
Bias & Framing
⚖
Article promotes specific stocks using IBD's proprietary screening criteria with minimal critical analysis or risk disclosure, presenting analyst estimates as reliable indicators without acknowledging forecast uncertainty.
Bias Direction
center-right
Confidence
HIGH
Promotional framing that positions IBD's screening methodology as authoritative and stocks as attractive opportunities; uses technical analysis language to suggest timing advantages; frames analyst consensus as validation without questioning accuracy.
analyst-backed profit growth potential
strong earnings
impressive 48% return on equity
passes all nine criteria
pleases analysts
friendly to buy again
well above the 17% minimum
Risks or downside scenarios for recommended stocks
Historical accuracy of analyst estimates or IBD screening methodology
Counterarguments or bearish analyst views
Disclosure of potential conflicts of interest (IBD benefits from increased trading activity)
Market conditions that could invalidate the screening criteria
Performance track record of similar recommendations
Alternative investment approaches or diversification strategies
Geopolitical Impact
🌎
This is a domestic financial analysis article about US stock investment opportunities, with no geopolitical implications or international dimensions.
Escalation Risk
low
Confidence
HIGH
Not applicable - this is a financial markets article focused on individual stock analysis rather than geopolitical affairs.
Economic Lens
📈
Three stocks (Merck, Simply Good Foods, PNM Resources) identified as having analyst-backed profit growth potential using CAN SLIM criteria, suggesting selective opportunities amid broader market downturn.
Market Signal
mixed
Confidence
MED
Pharmaceuticals
Consumer Staples/Food & Beverage
Utilities
Consumers may benefit from potential innovations in diabetes, obesity, and respiratory treatments from Merck; food/beverage consumers could see improved offerings from Simply Good Foods; utility customers may experience stable service from PNM Resources.
Pharmaceutical sector faces ongoing pricing regulation scrutiny; utilities remain subject to regulatory oversight on rates and service standards; continued focus on ESG criteria may influence investment screening methodologies.